1. Declaration of interests:

Jackie Baillie declared no relevant interests.

2. Decision on taking business in private:

The Committee decided to take items 6, 7 and 8 in private.

3. Transvaginal Mesh Removal (Cost Reimbursement) (Scotland) Bill:

The Committee took evidence on the Bill at Stage 1 from—

Dr Ros Jamieson, Clinical lead for the Complex Mesh National Surgical Service and Mark White,Director of Finance, NHS Greater Glasgow and Clyde ;

Dr Anna Lamont, Interim Medical Director, Procurement Commissioning and Facilities, Roseanne McDonald,Associate Director, Procurement Commissioning and Facilities and Paul Hornby,Head of Strategic Sourcing & Commercial, National Procurement, NHS National Services Scotland .

4. Transvaginal Mesh Removal (Cost Reimbursement) (Scotland) Bill:

The Committee took evidence on the Bill at Stage 1 from—

Humza Yousaf, Cabinet Secretary for Health and Social Care, Greig Chalmers,Head of Chief Medical Officer’s Policy Division, Terry O'Kelly,Senior Medical Adviser, David Bishop,Mesh Team Leader and Ailsa Garland,Solicitor, Scottish Government .

5. Subordinate legislation:

The Committee considered the following negative instruments— NHS Education for Scotland Amendment Order 2021
National Health Service (Free Prescriptions and Charges for Drugs and Appliances) (Scotland) Amendment Regulations 2021

6. Evidence Session

The Committee considered the evidence it heard earlier under agenda items 3 and 4.

7. Health and Wellbeing of Children and Young People:

The Committee agreed its approach to the inquiry.

8. Perinatal Mental Health:

The Committee agreed its approach to the inquiry.